Claritev Corporation (CTEV) Earnings Per Share (EPS)
Claritev Corporation (CTEV) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2020-12-31 | -$44.40 |
| 2021-12-31 | $6.40 |
| 2022-12-31 | -$36.00 |
| 2023-12-31 | -$5.60 |
| 2024-12-31 | -$101.92 |
| 2025-12-31 | -$17.30 |
How CTEV compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| AGIO | Agios Pharmaceuticals Inc. | -$7.12 |
| MRNA | Moderna Inc. | -$7.26 |
| NKTR | Nektar Therapeutics | -$9.73 |
| PRGO | Perrigo Company plc | -$10.29 |
| QDEL | QuidelOrtho Corp Com | -$16.69 |
These are five companies in the same sector as CTEV with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Claritev Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("CTEV")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CTEV | $38.12 | +0.00% | 0.22M |
| 3 | ||||
| 4 | ||||
| 5 |